J. E. Rossouw, G. L. Anderson, and R. L. Prentice, Risks an benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, Jama. Jama, vol.288291, pp.321-3331701, 2002.

E. Oger, Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale, Thromb Haemost, vol.83, pp.657-660, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00726218

F. A. Anderson, J. , H. B. Wheeler, and R. J. Goldberg, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study, Archives of Internal Medicine, vol.151, issue.5, pp.933-938, 1991.
DOI : 10.1001/archinte.151.5.933

M. Canonico, G. Plu-bureau, G. D. Lowe, and P. Y. Scarabin, Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis, BMJ, vol.336, issue.7655, pp.1227-1231, 2008.
DOI : 10.1136/bmj.39555.441944.BE

URL : https://hal.archives-ouvertes.fr/inserm-01142884

V. Olie, M. Canonico, and P. Y. Scarabin, Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women, Current Opinion in Hematology, vol.17, issue.5, pp.457-463, 2010.
DOI : 10.1097/MOH.0b013e32833c07bc

L. Manzoli, C. De-vito, C. Marzuillo, A. Boccia, and P. Villari, Oral Contraceptives and Venous Thromboembolism, Drug Safety, vol.20, issue.6, pp.191-205, 2012.
DOI : 10.2165/11598050-000000000-00000

P. Y. Scarabin, E. Oger, G. Plu-bureau, M. Canonico, E. Oger et al., Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. Arteriosclerosis, thrombosis, and vascular biology Hormone replacement therapy and the risk of venous thromboembolism: a population-based study Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy, Lancet. Circulation. J Thromb Haemost. Menopause, vol.36211530818, issue.11, pp.428-432840, 2003.

. Lokkegaard, Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, pp.2001-2010

1. N. Smith, S. R. Heckbert, and R. N. Lemaitre, Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database Age at menopause as a risk factor for cardiovascular mortality Hennekens, et al. Age at natural menopause and risk of cardiovascular disease, 21. M. J. de Kleijn, Y. T. van der Schouw, A. L. Verbeek, P. H. Peeters, J. D. Banga and Y. van der Graaf. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women 22. F. Atsma, M. L. Bartelink, D. E. Grobbee and Y. T. van der Schouw, pp.1581-1587, 1996.

R. Lakshman, N. G. Forouhi, and S. J. Sharp, Early age at menarche associated with cardiovascular disease and mortality Premature menopause or early menopause and risk of ischemic stroke, Postmenopausal status and early menopause as independent risk factors for cardiovascular disease, pp.265-2794953, 2006.

M. Wellons, P. Ouyang, P. J. Schreiner, D. M. Herrington, and D. Vaidya, Early menopause predicts future coronary heart disease and stroke, 27. C. A. van Wayenburg, Y. T. van der Schouw, P. A. van Noord and P. H, pp.1081-1087285, 1999.
DOI : 10.1097/gme.0b013e3182517bd0

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443540

. Peeters, Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort, Epidemiology (Cambridge, Mass, vol.11, pp.304-308, 2000.

C. C. Chang, H. F. Chiu, C. Y. Yang, S. C. Jansen, E. H. Temme et al., Parity, Age at First Birth, and Risk of Death From Pancreatic Cancer, Pancreas, vol.39, issue.5, pp.567-571105, 2002.
DOI : 10.1097/MPA.0b013e3181c7341e

L. T. Shuster, D. J. Rhodes, B. S. Gostout, B. R. Grossardt, W. A. Rocca et al., Premature menopause or early menopause: long-term health consequences Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome Parity and total, ischemic heart disease and stroke mortality. The Adventist Health Study Early age at menarche associated with increased all-cause mortality, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study, 36. M. M. Samama Beau Yon de Jonage-Canonico, E. Oger, et al. Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism, pp.161-166545, 1976.

P. L. Lutsey, B. A. Virnig, and S. B. Durham, Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study American journal of public health Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology, 40. Design of the Women's Health Initiative clinical trial and observational study, pp.1506-1513606, 2010.

4. A. Mctiernan, C. Kooperberg, and E. White, The Women's Health Initiative Study Group Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study, Controlled clinical trials. Jama, vol.19290, pp.61-1091331, 1998.

4. J. Palmer, L. Rosenberg, S. R. Shapiro-44, T. Ness, J. Harris et al., Reproductive factors and risk of myocardial infarction Number of pregnancies and the subsequent risk of cardiovascular disease. The New England journal of medicine Number of pregnancies and risk for stroke and stroke subtypes The association of reproductive history with all-cause and cardiovascular mortality in older women: the Rancho Bernardo Study, Risk of ischemic stroke and lifetime estrogen exposure, pp.26-31408, 1992.

R. Cui, H. Iso, and H. Toyoshima, Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study Reproductive risk factors for cardiovascular disease mortality among postmenopausal women in Korea: the Kangwha Cohort Study Hormone replacement therapy and risk of venous thromboembolism: population based case-control study Menopause with cardiovascular disease and its risk factors among rural Chinese women in Beijing: a population-based study, 52. N. Agrinier, M. Cournot, J. Dallongeville, et al. Menopause and modifiable coronary heart disease risk factors: a population based study, pp.177-1841205, 1985.

H. J. Baer, R. J. Glynn, and F. B. Hu, Risk Factors for Mortality in the Nurses' Health Study: A Competing Risks Analysis, American Journal of Epidemiology, vol.173, issue.3, pp.319-329, 2011.
DOI : 10.1093/aje/kwq368

M. Cushman, L. H. Kuller, and R. Prentice, Estrogen plus progestin and risk of venous thrombosis, Jama. Jama, vol.297292, pp.1465-1477, 2004.

J. D. Curb, R. L. Prentice, and P. F. Bray, Venous thrombosis and conjugated equine estrogen in women without a uterus Archives of internal medicine Progesterone receptor expression in human saphenous veins, Circulation, vol.16692, pp.772-7802975, 1995.